Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Oflowel-OR Tablets
Oflowel-OR Tablets provide effective treatment for mixed bacterial and protozoal infections. Combining Ofloxacin and Ornidazole, this trusted formulation offers broad-spectrum antimicrobial action, ensuring comprehensive relief from complex infections.
Uses of Oflowel-OR Tablets
Treatment of intestinal infections caused by both bacteria and protozoa
Management of mixed diarrhea syndromes and gastrointestinal infections
Effective against certain gynecological and dental infections involving anaerobic pathogens
Suitable for post-surgical infections and abdominal infections requiring broad-spectrum coverage
Benefits of Oflowel-OR Tablets
Dual-action therapy, targeting a wide range of bacterial and protozoal pathogens
Proven safety and efficacy, trusted by healthcare providers worldwide
Convenient twice-daily dosing, ensuring ease of administration and improved compliance
Rapid symptom relief, promoting faster recovery and improved quality of life
Comprehensive coverage, reducing the need for multiple medications
Mechanism of Action of Oflowel-OR Tablets
Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, preventing bacterial replication and growth.
Ornidazole disrupts DNA synthesis in anaerobic bacteria and protozoa, leading to their elimination.
Together, they provide broad-spectrum antimicrobial activity, effectively treating mixed infections at their source.